Publication | Open Access

Medications mostly associated with priapism events: assessment of the 2015–2020 Food and Drug Administration (FDA) pharmacovigilance database entries

Drug SafetyHealth PolicyClinical EpidemiologyPopulation Health SciencesPharmacovigilance Database EntriesDrug MonitoringPharmacotherapyDrug AdministrationPublic HealthDrug AssessmentMedicineHarm ReductionAdverse Drug ReactionPriapism Events